These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8692546)

  • 1. Serotonin mechanisms in chemotherapy-induced emesis in cancer patients.
    Cubeddu LX
    Oncology; 1996 Jun; 53 Suppl 1():18-25. PubMed ID: 8692546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms by which cancer chemotherapeutic drugs induce emesis.
    Cubeddu LX
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):2-13. PubMed ID: 1485177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies.
    Cubeddu LX; O'Connor DT; Hoffmann I; Parmer RJ
    Br J Cancer; 1995 Oct; 72(4):1033-8. PubMed ID: 7547218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.
    Castejon AM; Paez X; Hernandez L; Cubeddu LX
    J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs.
    Cubeddu LX; Hoffmann IS; Fuenmayor NT; Malave JJ
    Br J Cancer; 1992 Jul; 66(1):198-203. PubMed ID: 1379060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serotonin and anticancer drug-induced emesis].
    Minami M; Endo T; Hamaue N; Hirafuji M
    Yakugaku Zasshi; 2004 Aug; 124(8):491-507. PubMed ID: 15297719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The severity and pattern of emesis following different cytotoxic agents.
    Martin M
    Oncology; 1996 Jun; 53 Suppl 1():26-31. PubMed ID: 8692547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus.
    Horikoshi K; Yokoyama T; Kishibayashi N; Ohmori K; Ishii A; Karasawa A
    Jpn J Pharmacol; 2001 Jan; 85(1):70-4. PubMed ID: 11243577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of serotonin in emesis].
    Minami M; Endo T; Hirafuji M
    Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):233-42. PubMed ID: 8974084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models.
    Naylor RJ; Rudd JA
    Oncology; 1996 Jun; 53 Suppl 1():8-17. PubMed ID: 8692557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon.
    Preziosi P; D'Amato M; Del Carmine R; Martire M; Pozzoli G; Navarra P
    Eur J Pharmacol; 1992 Oct; 221(2-3):343-50. PubMed ID: 1426010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis.
    du Bois A; Vach W; Kiechle M; Cramer-Giraud U; Meerpohl HG
    Oncology; 1996 Jun; 53 Suppl 1():46-50. PubMed ID: 8692551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of cytotoxic drug-induced emesis and its prevention].
    Matsuki N
    Yakugaku Zasshi; 1996 Sep; 116(9):710-8. PubMed ID: 8855716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model.
    Endo T; Hamaue N; Ihira E; Teramoto Y; Liu Y; Hirafuji M; Minami M
    Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):55-68. PubMed ID: 14632314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dual effect of some 5-HT3 receptor antagonists on cisplatin-induced emesis in the pigeon.
    Navarra P; Martire M; del Carmine R; Pozzoli G; Preziosi P
    Toxicol Lett; 1992 Dec; 64-65 Spec No():745-9. PubMed ID: 1471230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral serotonin type 3-receptor antagonists for prevention of chemotherapy-induced emesis.
    Lindley C; Blower P
    Am J Health Syst Pharm; 2000 Sep; 57(18):1685-97. PubMed ID: 11006796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists.
    Tyers MB; Freeman AJ
    Oncology; 1992; 49(4):263-8. PubMed ID: 1387926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy.
    Cubeddu LX; O'Connor DT; Parmer RJ
    J Clin Oncol; 1995 Mar; 13(3):681-7. PubMed ID: 7533826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of zatosetron on ipecac-induced emesis in dogs and healthy men.
    Schwartz SM; Goldberg MJ; Gidda JS; Cerimele BJ
    J Clin Pharmacol; 1994 Mar; 34(3):250-4. PubMed ID: 7517409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective blockade of cytotoxic drug-induced emesis by 5-HT3 receptor antagonists in Suncus murinus.
    Torii Y; Saito H; Matsuki N
    Jpn J Pharmacol; 1991 Jan; 55(1):107-13. PubMed ID: 2041220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.